American Century Companies’s Edwards Lifesciences EW Stock Holding History

American Century Companies’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.96M	Sell	111,902 -23,582	-17%	-$1.94M	﹤0.01%	1510
2025 Q4	$11.6M	Sell	135,484 -74,847	-36%	-$6.14M	0.01%	1385
2025 Q3	$16.4M	Sell	210,331 -14,035	-6%	-$1.1M	0.01%	1231
2025 Q2	$17.5M	Sell	224,366 -1,049,818	-82%	-$78.3M	0.01%	1150
2025 Q1	$92.4M	Buy	1,274,184 +108,127	+9%	+$7.74M	0.06%	361
2024 Q4	$86.3M	Sell	1,166,057 -684,027	-37%	-$47.9M	0.05%	387
2024 Q3	$122M	Sell	1,850,084 -232,877	-11%	-$16.9M	0.07%	284
2024 Q2	$192M	Buy	2,082,961 +43,247	+2%	+$3.83M	0.12%	167
2024 Q1	$195M	Sell	2,039,714 -76,615	-4%	-$6.44M	0.12%	171
2023 Q4	$161M	Sell	2,116,329 -271,810	-11%	-$18.9M	0.11%	205
2023 Q3	$165M	Buy	2,388,139 +36,129	+2%	+$2.9M	0.13%	181
2023 Q2	$222M	Sell	2,352,010 -172,810	-7%	-$15M	0.17%	136
2023 Q1	$209M	Sell	2,524,820 -1,803,547	-42%	-$142M	0.16%	148
2022 Q4	$323M	Buy	4,328,367 +473,547	+12%	+$36.5M	0.26%	90
2022 Q3	$319M	Buy	3,854,820 +9,637	+0.3%	+$927K	0.28%	74
2022 Q2	$366M	Sell	3,845,183 -48,244	-1%	-$4.99M	0.3%	72
2022 Q1	$458M	Sell	3,893,427 -233,665	-6%	-$26.2M	0.31%	67
2021 Q4	$535M	Sell	4,127,092 -298,865	-7%	-$34.9M	0.34%	62
2021 Q3	$501M	Buy	4,425,957 +184,057	+4%	+$21M	0.34%	63
2021 Q2	$439M	Buy	4,241,900 +38,704	+0.9%	+$3.65M	0.3%	73
2021 Q1	$352M	Sell	4,203,196 -11,980	-0.3%	-$1.01M	0.26%	97
2020 Q4	$385M	Sell	4,215,176 -361,607	-8%	-$30M	0.3%	79
2020 Q3	$365M	Sell	4,576,783 -40,907	-0.9%	-$3.19M	0.32%	69
2020 Q2	$319M	Sell	4,617,690 -7,923	-0.2%	-$563K	0.3%	85
2020 Q1	$291M	Buy	4,625,613 +509,145	+12%	+$36.7M	0.35%	72
2019 Q4	$320M	Sell	4,116,468 -729,366	-15%	-$57M	0.3%	88
2019 Q3	$355M	Buy	4,845,834 +1,026,738	+27%	+$72.1M	0.36%	70
2019 Q2	$235M	Sell	3,819,096 -1,824,585	-32%	-$110M	0.23%	120
2019 Q1	$360M	Buy	5,643,681 +374,787	+7%	+$21.4M	0.36%	68
2018 Q4	$269M	Sell	5,268,894 -410,052	-7%	-$20.7M	0.31%	81
2018 Q3	$330M	Sell	5,678,946 -1,628,574	-22%	-$79.7M	0.32%	84
2018 Q2	$355M	Sell	7,307,520 -1,061,643	-13%	-$49.6M	0.36%	67
2018 Q1	$389M	Buy	8,369,163 +2,209,395	+36%	+$95.9M	0.4%	63
2017 Q4	$231M	Sell	6,159,768 -512,262	-8%	-$18.8M	0.23%	133
2017 Q3	$243M	Buy	6,672,030 +434,103	+7%	+$16.6M	0.25%	123
2017 Q2	$246M	Buy	6,237,927 +97,302	+2%	+$3.55M	0.25%	120
2017 Q1	$193M	Buy	6,140,625 +413,802	+7%	+$13M	0.2%	150
2016 Q4	$179M	Buy	5,726,823 +1,427,889	+33%	+$46.3M	0.19%	161
2016 Q3	$173M	Buy	4,298,934 +27,684	+0.6%	+$1.04M	0.19%	158
2016 Q2	$142M	Buy	4,271,250 +1,938,426	+83%	+$66.3M	0.16%	180
2016 Q1	$68.6M	Buy	2,332,824 +63,381	+3%	+$1.75M	0.08%	310
2015 Q4	$59.7M	Buy	+2,269,443	New	+$58.9M	0.07%	337
2015 Q3	–	Sell	-757,872	Closed	-$18M	–	1362
2015 Q2	$18M	Buy	757,872 +76,260	+11%	+$1.72M	0.02%	578
2015 Q1	$16.2M	Buy	681,612 +641,406	+1,595%	+$14.4M	0.02%	584
2014 Q4	$854K	Buy	40,206 +8,658	+27%	+$174K	﹤0.01%	1210
2014 Q3	$537K	Buy	+31,548	New	+$498K	﹤0.01%	1274

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

American Century Companies's EW Position: Q1 2026 in Review

American Century Companies reduced its Edwards Lifesciences (EW) stake by 17% in Q1 2026, selling an estimated $1.94M and leaving 111,902 shares worth $8.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

American Century Companies first reported a position in EW in Q3 2014 and has held it in 46 quarters since. The position peaked at $535M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

American Century Companies held 111,902 shares of Edwards Lifesciences worth $8.96M as of Q1 2026.
American Century Companies sold 23,582 Edwards Lifesciences shares in Q1 2026, an estimated $1.94M.
Edwards Lifesciences made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #1510 holding.
American Century Companies first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 46 quarters since.
American Century Companies's Edwards Lifesciences position peaked at $535M in Q4 2021.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.